Nonetheless, Glenn Micalizio, a chemist at Scripps, and his colleagues did not come to be interested in the compound on account of its pharmaceutical opportunity. Relatively, they recognized that its complicated carbon skeleton was an excellent goal for tests a style of reaction that they had a